(KOD) – Corporate News
-
Kodiak Sciences Inc. (KOD) Reports Topline Data for tarcocimab tedromer
-
Kodiak Sciences (KOD) Reports Topline Results from its Phase 3 Studies of Tarcocimab Tedromer
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to KOD Stock Lookup